Surgical Specialty Center Of Baton Rouge Is First Hospital In Southern Louisiana To Enhance Patient Safety By Deploying A Xenex Lightstrike Germ-Zapping Robot

BATON ROUGE, La.--(BUSINESS WIRE)--Surgical Specialty Center of Baton Rouge today announced it is the first healthcare facility in southern Louisiana to deploy a Xenex LightStrike™ Germ-Zapping Robot™ to destroy potentially lethal germs and bacteria lurking in rooms that can pose a risk to patient and employee safety.

The new Xenex Robot uses Full Spectrum™ pulsed xenon ultraviolet (UV) light to quickly destroy bacteria, viruses, fungi and bacterial spores. The portable disinfection system is effective against even the most dangerous pathogens, including Clostridium difficile (C.diff), norovirus, influenza, and methicillin-resistant Staphylococcus aureus, better known as MRSA. Surgical Specialty Center of Baton Rouge is using its LightStrike Robot to disinfect its 16 patient rooms and 10 Operating Rooms (ORs) at the end of the day after the rooms have been cleaned via traditional methods. They are also disinfecting the ORs before total joint cases to further reduce the risk of infection.

“We want to do everything within our means to provide a clean environment to reduce the risk of hospital acquired infections,” said Ann Heine, CEO of Surgical Specialty Center of Baton Rouge. “As we continue to focus on patient outcomes, we believe that one infection is too many. Patient safety is a top priority of ours and this investment underscores our commitment to the patients we serve.”

The portable Xenex system can disinfect a typical patient or procedure room in 10-15 minutes without warm-up or cool-down times. It can be used in any department and in any unit within a healthcare facility, including isolation rooms, operating rooms, general patient care rooms, contact precaution areas, emergency rooms, bathrooms and public spaces.

The Xenex system has been credited by healthcare facilities across the U.S. for helping them reduce their infection rates significantly. Several hospitals have published their C.diff, MRSA and Surgical Site infection rate reduction studies in peer-reviewed journals - showing infection rate reductions in excess of 70 percent. Over 400 healthcare facilities in the U.S. are utilizing the Xenex technology, as well as hospitals in Canada, Africa, Japan, the UK, and throughout Europe.

Xenex Disinfection Services

Xenex’s patented Full Spectrum^TM pulsed xenon UV room disinfection system is used for the advanced disinfection of healthcare facilities. Due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. Xenex’s mission is to save lives and reduce suffering by destroying the deadly microorganisms that cause hospital acquired infections (HAIs). The company is backed by well-known investors that include EW Healthcare Partners, Piper Jaffray Merchant Banking, Malin Corporation, Battery Ventures, Targeted Technology Fund II, Tectonic Ventures and RK Ventures. For more information, visit Xenex.com.